John Wiley & Sons (NYSE: JW . A ): FQ1 EPS of $0.56 beats by $0.03 . Revenue of $438M (+6.6% Y/Y) beats by $7.51M . Press Release Post your comment!
BKS , FRAN , HDS , JW . A , LAYN , LDOS , TITN Post your comment!
funding environment in the U.S. and Europe continues to face headwinds. We view the top-tier journal companies like Reed Elsevier and John Wiley & Sons JW . A as gaining market share in an overall pie with limited growth at the present time.
compared with older real estate and declining traffic and demographic patterns of many older department stores. John Wiley & Sons JW . A Wiley is an intriguing value play. There is negative market sentiment on Wiley because the company faces a decline in its college
John Wiley JW . A reported disappointing fourth-quarter results and fiscal 2014 earnings per share guidance of $2.85-$2.95, which was
John Wiley JW . A reported disappointing fourth-quarter results, and its flat fiscal 2014 earnings per share guidance of $2.85-$2.95 was
John Wiley & Sons JW . A named John Kritzmacher as chief financial officer, effective July 1, 2013. Kritzmacher will be responsible for all of Wiley's
yielding returns on capital well above those of its peers, validating the company's wide economic moat. John Wiley & Sons JW . A | Fair Value Uncertainty: Medium | Market Cap: $2.3 Billion From the Premium Analyst Report : John Wiley & Sons' science
shippers and carriers bestows a robust economic moat that should help protect economic profits for years to come. John Wiley & Sons JW . A | Fair Value Uncertainty: Medium From the Premium Analyst Report : John Wiley & Sons' science, technology, medical, and
We see several positives after analyzing John Wiley's JW . A third-quarter results, and we are sticking with our $45 fair value estimate and wide moat rating. The company generated organic